Monday, November 16, 2020 to Thursday, December 17, 2020 (registration required)
The National Cancer Institute's (NCI) Cancer Target Discovery and Development (CTD2) Network and Cancer Systems Biology Consortium (CSBC) are organizing a virtual, multi-date symposium designed to highlight research focused on understanding the mechanisms of cancer therapy resistance and sensitivity using systems-level approaches. The symposium is planned over five days with four scientific themes: approaches to design combination therapies (November 16); evolutionary biology approaches to understand resistance (November 17); the role of the tumor ecosystem in drug resistance and sensitivity (December 2); and tumor heterogeneity and cell plasticity during therapy (December 16 and 17).
Each virtual mini-symposium will be two hours in length (12:00 p.m. ET – 2:00 p.m. ET) and feature five talks from leaders in the fields of cancer biology and systems biology. The first session will kick-off with remarks from NCI Director Dr. Ned Sharpless at 11:30 a.m. ET. Sli.do-based question collection will be utilized to collect the most pressing questions from the audience. Please join the CTD2 and CSBC for this exciting series.
Tuesday, December 15, 2020 to Friday, December 18, 2020 (register by December 4)
This virtual workshop will highlight the state of the science in cannabis, its chemical constituents (e.g., cannabinoids) and cancer research, including cancer epidemiology, use in cancer patients, cancer biology and prevention, pre-clinical and clinical cancer symptom and treatment side-effect management, as well as the use of cannabis and cannabinoids as cancer therapeutics. The workshop will also address current barriers to research and strategies to navigate these hurdles to ensure feasibility of rigorous studies designed to address gaps in knowledge as well as potential research opportunities in the area of cannabis cancer-related research.
Monday, March 1, 2021, 10:30 am to 5:30 pm (registration required)
Rare Disease Day takes place worldwide, typically on or near the last day of February each year, to raise awareness among policymakers and the public about rare diseases and their impact on patients’ lives. Each year, NIH's National Center for Advancing Translational Sciences (NCATS) and the NIH Clinical Center sponsor Rare Disease Day at NIH as part of this global observance. Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and NIH research collaborations underway to address scientific challenges and to advance new treatments.
This year, Rare Disease Day at NIH will be held virtually. This year’s event will feature interactive panel discussions, rare stories through TED-style talks, and more. The event is free and open to the public, including patients, patient advocates, health care providers, researchers, industry representatives and government employees. Registration is required for the event.
